Connection
Shanta Zimmer to Cost-Benefit Analysis
This is a "connection" page, showing publications Shanta Zimmer has written about Cost-Benefit Analysis.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
0.037 |
|
|
|
-
Lee BY, Tai JH, McGlone SM, Bailey RR, Wateska AR, Zimmer SM, Zimmerman RK, Wagner MM. The potential economic value of a 'universal' (multi-year) influenza vaccine. Influenza Other Respir Viruses. 2012 May; 6(3):167-75.
Score: 0.019
-
Lee BY, Stalter RM, Bacon KM, Tai JH, Bailey RR, Zimmer SM, Wagner MM. Cost-effectiveness of adjuvanted versus nonadjuvanted influenza vaccine in adult hemodialysis patients. Am J Kidney Dis. 2011 May; 57(5):724-32.
Score: 0.018